APLN and neoplasm: Importantly, sunitinib‐treated NeuT;Apln−/− tumors showed a significant decrease in tumor growth (Fig 3C and Movie EV1), as well as reduced mitotic counts and Ki67 staining (Figs 3D and EV4D).